Markets:

Overview

News

Currencies

International

Treasuries

Bristol-Myers Squibb (NY:BMY)

55.26 -1.36 (-2.40%)

Official Closing Price Updated: 7:00 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bristol-Myers Squibb

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

85 86 Next >

1 Stock Under $50 with Solid Fundamentals and 2 to Keep Off Your Radar

May 02, 2025

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some...

Via StockStory

Bristol-Myers Squibb Co (NYSE:BMY): A High-Yield Dividend Stock Worth Considering ↗

April 30, 2025

Bristol-Myers Squibb Co (NYSE:BMY): A High-Yield Dividend Stock Worth Considering

Via Chartmill

This High-Yield Pharma Stock Looks Like an Incredible Bargain ↗

April 30, 2025

Via The Motley Fool

Topics Intellectual Property

Don’t Be Fooled by the Bounce: The Market Storm Isn’t Over Yet

April 29, 2025

Recent upticks in the market may disguise the ongoing risks that remain for investors; these factors point to the importance of a defensive strategy.

Via MarketBeat

Topics Economy Government World Trade

Earnings Scheduled For April 24, 2025 ↗

April 24, 2025

Via Benzinga

Large Cap Biopharmaceutical Update: Mixed Performance As Tariffs Loom ↗

April 28, 2025

Biopharma stocks rally along with many of our SMID cap trades. The market situation with pharmaceuticals is even more complicated because we started off with legislation (the IRA) trying to curb rising...

Via Talk Markets

Topics ETFs Stocks / Equities

Top 3 Health Care Stocks That May Rocket Higher In April ↗

April 28, 2025

Via Benzinga

Pfizer (PFE) Reports Q1: Everything You Need To Know Ahead Of Earnings

April 28, 2025

Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting earnings tomorrow before market hours. Here’s what you need to know.

Via StockStory

Topics Government World Trade

4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off ↗

April 26, 2025

Via The Motley Fool

Topics Economy Intellectual Property World Trade

S&P 500 Rallies 2% On Nvidia, Tesla Gains — But Market Mood Stuck In 'Fear' ↗

April 25, 2025

Via Benzinga

Topics Stocks

Gold Gains 1%; Bristol Myers Squibb Posts Upbeat Results ↗

April 24, 2025

Via Benzinga

Bristol Myers Delivers Upbeat 2025 Forecast Despite China Tariffs Impact ↗

April 24, 2025

Bristol Myers reported Q1 revenue of $11.2 billion, raised 2025 guidance, and saw strong Growth Portfolio sales offset Legacy product declines.

Via Benzinga

Bristol Myers Reports Upbeat Q1 Earnings, Raises Full-Year Guidance: Retail’s Optimistic ↗

April 24, 2025

The company now expects full-year diluted EPS in the range of $6.70 to $7.00, up from its previous guidance of $6.55 to $6.85.

Via Stocktwits

Topics World Trade

Wall Street Rally Extends Into Third Day: What's Driving Markets Thursday? ↗

April 24, 2025

U.S. equities are pushing higher for a third straight session, eyeing the longest winning streak since the Trump tariff announcement on April 2, as optimism over corporate earnings and easing trade...

Via Benzinga

Topics Government World Trade

Bristol Myers Continues A Two-Day Losing Spree Despite Walloping Earnings Estimates ↗

April 24, 2025

The company recently faced two big clinical trial setbacks that have weighed on shares recently.

Via Investor's Business Daily

Topics Government

Bristol-Myers Squibb (NYSE:BMY) Reports Upbeat Q1, Full-Year Outlook Slightly Exceeds Expectations

April 24, 2025

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 5.6% year on year to $11.2 billion. The company’s...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Bristol Myers Squibb Reports First Quarter Financial Results for 2025

April 24, 2025

From Bristol Myers Squibb

Via Business Wire

US Stock Futures Drop Amid Mixed Signals From White House On US-China Trade: 'Focus On Quality In A Diversified Manner,' Says Expert ↗

April 24, 2025

U.S. stock futures fell on Thursday after a two-day advance. Futures of major benchmark indices were lower in premarket.

Via Benzinga

PepsiCo, Alphabet And 3 Stocks To Watch Heading Into Thursday ↗

April 24, 2025

Via Benzinga

Dow Jumps Over 400 Points Amid China Tariff Hopes, Investor Fear Eases: Greed Index Remains In 'Fear' Zone ↗

April 24, 2025

Via Benzinga

Topics Stocks

Stay informed with the top movers within the S&P500 index on Wednesday. ↗

April 23, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Explore the top gainers and losers within the S&P500 index in today's session. ↗

April 23, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

What's going on in today's pre-market session: S&P500 movers ↗

April 23, 2025

Discover the top S&P500 movers in Wednesday's pre-market session and stay informed about market dynamics.

Via Chartmill

Tesla To $303? Here Are 10 Top Analyst Forecasts For Wednesday ↗

April 23, 2025

Via Benzinga

Bristol Myers' Cobenfy Falls Short On Primary Endpoint In Phase 3 Schizophrenia Trial, Stock Slides ↗

April 23, 2025

Bristol Myers' Cobenfy missed its primary endpoint in the Phase 3 ARISE trial but showed symptom improvement in certain subgroups.

Via Benzinga

Bristol-Myers Squibb (BMY) Reports Earnings Tomorrow: What To Expect

April 23, 2025

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be announcing earnings results tomorrow morning. Here’s what investors should know.

Via StockStory

Bristol Myers Squibb Stock Slides After-Hours As Schizophrenia Trial Misses Goal, But Retail's Buying The Dip ↗

April 23, 2025

A post-hoc analysis showed more pronounced effects among patients on risperidone compared to those on other antipsychotics, the company said.

Via Stocktwits

Topics Intellectual Property

Stay updated with the S&P500 stocks that are on the move in today's after-hours session. ↗

April 22, 2025

After the closing bell on Tuesday, let's take a glimpse of the US markets and explore the top S&P500 gainers and losers in today's after-hours session.

Via Chartmill

Beyond The Numbers: 7 Analysts Discuss Bristol-Myers Squibb Stock ↗

April 22, 2025

Via Benzinga

Bristol Myers Sheds 6% After Promising Schizophrenia Drug Flops In Phase 3 Test ↗

April 22, 2025

The company spent $14 billion to acquire the developer of this drug, Cobenfy.

Via Investor's Business Daily

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

85 86 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.